Adient initiated with a Buy at Stifel

Stifel initiated coverage of Adient (ADNT) with a Buy rating and $27 price target The firm expects improved free cash flow driven by higher margins, citing improved contract pricing and terms, the roll off of the unprofitable metals business, benefits from a European restructuring, and growth in China, the analyst tells investors.